Skip to main content
Premium Trial:

Request an Annual Quote

EnviroLogix Licenses Ionian's Nucleic Acid Technology

NEW YORK (GenomeWeb News) — Plant diagnostics firm EnviroLogix has licensed nucleic acid technology from Ionian Technologies that it will use in tests for the agricultural, plant pathogen, and veterinary testing markets, EnviroLogix said today.
 
Portland, Maine-based EnviroLogix, which offers on-site and lab-based immunoassays for detecting transgenic proteins, has licensed Ionian’s Nicking Enzyme Amplification Reaction (NEAR) technology under an exclusive and worldwide license and technology transfer agreement.
 
The tests will use Ionian’s isothermal amplification methods to detect DNA and RNA in less than 10 minutes with the same sensitivity as PCR-based tests, EnviroLogix said. The NEAR technology can be used to “detect single base changes between two otherwise similar sequences,” and the amplification products can be detected using both fluorescent and lateral flow methods, the firm said.
 
EnviroLogix has developed tests for detection of mold, mycotoxins, algal toxins, pesticides, and plant pathogens.
 
Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.